Tag: automated cell cultures market forecast

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Automated Cell Cultures Market Value Analysis: What Growth Is Expected Over The Forecast Period?

The market for automated cell cultures has experienced significant expansion lately, with projections indicating a substantial increase from $7.02 billion in 2025 to $7.78 billion in 2026, reflecting a compound annual growth rate of 10.8%. This robust growth trajectory is underpinned by several key factors that fueled its development historically: a surge in biopharmaceutical research endeavors, a growing need for consistent and repeatable cell culture methodologies, the acceleration of drug discovery initiatives, the accessibility of adaptable automation systems, and the flourishing of life science investigations within academic institutions.

The automated cell cultures sector is poised for significant expansion in the coming years, projected to reach a market valuation of $11.58 billion by the year 2030, driven by a compound annual growth rate of 10.5%. This anticipated growth during the forecast period is underpinned by several key factors, including escalating investments in the production of cell and gene therapies, a heightened demand for efficient high-throughput screening processes, the burgeoning field of personalized medicine research, the increasing integration of automation within laboratory environments, and an intensified emphasis on enabling the scalable manufacturing of biologics. Furthermore, prominent trends anticipated to shape this market include the greater implementation of completely automated cell culture platforms, the wider adoption of robotic systems for liquid handling, the expanding utilization of scalable automation solutions for cell culture, the advancement of closed-system cell processing techniques, and a strengthened focus on ensuring reproducibility and maintaining stringent sterility controls.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20499&type=smp

Automated Cell Cultures Market Industry Drivers: What Is Driving Revenue Growth?

The expansion of biopharmaceutical manufacturing is anticipated to fuel the advancement of the automated cell culture sector moving ahead. Biopharmaceuticals, which are medications developed through biotechnological means such as recombinant DNA technology and cell cultivation, are seeing elevated demand due to their capacity for precise, potent therapies with minimized adverse effects compared to conventional treatments. Automated cell culture systems contribute to improved efficiency and uniformity in biopharmaceutical output by optimizing the stages of cell proliferation, surveillance, and collection. Substantiating this trend, Sartorius, a German entity specializing in life science technologies, reported in July 2025 that worldwide revenues from biopharmaceutical medications ascended by approximately 9% to USD 458 billion in 2024, a rise from the prior year, representing 41% of the overall pharmaceutical market share, up from 40% in 2023. Consequently, the escalating output of biopharmaceuticals is acting as a catalyst for the growth observed in the automated cell culture market.

#Automated Cell Cultures Market Segment Landscape And Growth Potential

The automated cell cultures market covered in this report is segmented –

1) By Type: Modular Automation, Whole Label Automation

2) By Equipment Type: Automated Liquid Handling Systems, Microplate Readers, Robotic Systems, Automated Storage And Retrieval Systems, Other Equipment Types

3) By Application: Biopharmaceuticals Production, Diagnostics, Gene Therapy, Drug Screening And Development, Toxicity Testing, Stem Cell Research, Tissue Engineering And Regenerative Medicine, Personalized Medicine, Other Applications

4) By End User: Pharmaceuticals And Biotechnology Companies, Hospital And Diagnostic Laboratories, Research Institutes, Cell Banks

Subsegments:

1) By Modular Automation: Automated Cell Culture Systems, Robotic Workstations, Modular Bioreactors

2) By Whole Label Automation: Fully Automated Cell Culture Systems, Integrated Cell Culture Platforms, Automated Cell Handling Solutions

#Automated Cell Cultures Market Growth Trends: What Is Influencing The Future Outlook?

The leading entities within the automated cell cultures sector are prioritizing innovation through sophisticated technologies, including artificial intelligence (AI) driven software, as a strategic means to secure market prominence. This integration of AI software in automated cell culture systems serves to refine experimental parameters and boost operational effectiveness by processing live data, thereby promoting superior cell proliferation and output. A notable development occurred in October 2023 when Molecular Devices LLC, a prominent biotechnology firm headquartered in the United States, introduced its CellXpress.ai Automated Cell Culture System, a pioneering solution engineered to accelerate drug discovery initiatives via cutting-edge automation and AI capabilities. This platform is specifically developed to simplify intricate cell culture procedures, liberating scientists to concentrate on more vital aspects of their research while simultaneously elevating both efficiency and dependability.

Automated Cell Cultures Market Competitive Landscape: Who Are The Leading Companies?

Major companies operating in the automated cell cultures market are Hitachi Ltd., Panasonic Holdings Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Corning Incorporated, Lonza Group AG, Nikon healthcare, Sartorius AG, Beckman Coulter Inc., Celltrio Inc., Eppendorf AG, Tecan Trading AG, Shibuya Corp, Hamilton Company, Molecular Devices LLC, FORMULATRIX, Highres Biosolutions, Biotron Healthcare, Agilent Technologies, Miltenyi Biotec

Access The Complete Automated Cell Cultures Market Report:

https://www.thebusinessresearchcompany.com/report/automated-cell-cultures-global-market-report

#Automated Cell Cultures Market Largest Region: Which Geography Holds The Highest Market Share?

North Americawas the largest region in the automated cell cultures market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the automated cell cultures market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Automated Cell Cultures Market Value Analysis: What Growth Is Expected Over The Forecast Period?

The market for automated cell cultures has experienced significant expansion lately, with projections indicating a substantial increase from $7.02 billion in 2025 to $7.78 billion in 2026, reflecting a compound annual growth rate of 10.8%. This robust growth trajectory is underpinned by several key factors that fueled its development historically: a surge in biopharmaceutical research endeavors, a growing need for consistent and repeatable cell culture methodologies, the acceleration of drug discovery initiatives, the accessibility of adaptable automation systems, and the flourishing of life science investigations within academic institutions.

The automated cell cultures sector is poised for significant expansion in the coming years, projected to reach a market valuation of $11.58 billion by the year 2030, driven by a compound annual growth rate of 10.5%. This anticipated growth during the forecast period is underpinned by several key factors, including escalating investments in the production of cell and gene therapies, a heightened demand for efficient high-throughput screening processes, the burgeoning field of personalized medicine research, the increasing integration of automation within laboratory environments, and an intensified emphasis on enabling the scalable manufacturing of biologics. Furthermore, prominent trends anticipated to shape this market include the greater implementation of completely automated cell culture platforms, the wider adoption of robotic systems for liquid handling, the expanding utilization of scalable automation solutions for cell culture, the advancement of closed-system cell processing techniques, and a strengthened focus on ensuring reproducibility and maintaining stringent sterility controls.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20499&type=smp

Automated Cell Cultures Market Industry Drivers: What Is Driving Revenue Growth?

The expansion of biopharmaceutical manufacturing is anticipated to fuel the advancement of the automated cell culture sector moving ahead. Biopharmaceuticals, which are medications developed through biotechnological means such as recombinant DNA technology and cell cultivation, are seeing elevated demand due to their capacity for precise, potent therapies with minimized adverse effects compared to conventional treatments. Automated cell culture systems contribute to improved efficiency and uniformity in biopharmaceutical output by optimizing the stages of cell proliferation, surveillance, and collection. Substantiating this trend, Sartorius, a German entity specializing in life science technologies, reported in July 2025 that worldwide revenues from biopharmaceutical medications ascended by approximately 9% to USD 458 billion in 2024, a rise from the prior year, representing 41% of the overall pharmaceutical market share, up from 40% in 2023. Consequently, the escalating output of biopharmaceuticals is acting as a catalyst for the growth observed in the automated cell culture market.

#Automated Cell Cultures Market Segment Landscape And Growth Potential

The automated cell cultures market covered in this report is segmented –

1) By Type: Modular Automation, Whole Label Automation

2) By Equipment Type: Automated Liquid Handling Systems, Microplate Readers, Robotic Systems, Automated Storage And Retrieval Systems, Other Equipment Types

3) By Application: Biopharmaceuticals Production, Diagnostics, Gene Therapy, Drug Screening And Development, Toxicity Testing, Stem Cell Research, Tissue Engineering And Regenerative Medicine, Personalized Medicine, Other Applications

4) By End User: Pharmaceuticals And Biotechnology Companies, Hospital And Diagnostic Laboratories, Research Institutes, Cell Banks

Subsegments:

1) By Modular Automation: Automated Cell Culture Systems, Robotic Workstations, Modular Bioreactors

2) By Whole Label Automation: Fully Automated Cell Culture Systems, Integrated Cell Culture Platforms, Automated Cell Handling Solutions

#Automated Cell Cultures Market Growth Trends: What Is Influencing The Future Outlook?

The leading entities within the automated cell cultures sector are prioritizing innovation through sophisticated technologies, including artificial intelligence (AI) driven software, as a strategic means to secure market prominence. This integration of AI software in automated cell culture systems serves to refine experimental parameters and boost operational effectiveness by processing live data, thereby promoting superior cell proliferation and output. A notable development occurred in October 2023 when Molecular Devices LLC, a prominent biotechnology firm headquartered in the United States, introduced its CellXpress.ai Automated Cell Culture System, a pioneering solution engineered to accelerate drug discovery initiatives via cutting-edge automation and AI capabilities. This platform is specifically developed to simplify intricate cell culture procedures, liberating scientists to concentrate on more vital aspects of their research while simultaneously elevating both efficiency and dependability.

Automated Cell Cultures Market Competitive Landscape: Who Are The Leading Companies?

Major companies operating in the automated cell cultures market are Hitachi Ltd., Panasonic Holdings Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Corning Incorporated, Lonza Group AG, Nikon healthcare, Sartorius AG, Beckman Coulter Inc., Celltrio Inc., Eppendorf AG, Tecan Trading AG, Shibuya Corp, Hamilton Company, Molecular Devices LLC, FORMULATRIX, Highres Biosolutions, Biotron Healthcare, Agilent Technologies, Miltenyi Biotec

Access The Complete Automated Cell Cultures Market Report:

https://www.thebusinessresearchcompany.com/report/automated-cell-cultures-global-market-report

#Automated Cell Cultures Market Largest Region: Which Geography Holds The Highest Market Share?

North Americawas the largest region in the automated cell cultures market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the automated cell cultures market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Automated Cell Cultures Market Value Analysis: What Growth Is Expected Over The Forecast Period?

The market for automated cell cultures has experienced significant expansion lately, with projections indicating a substantial increase from $7.02 billion in 2025 to $7.78 billion in 2026, reflecting a compound annual growth rate of 10.8%. This robust growth trajectory is underpinned by several key factors that fueled its development historically: a surge in biopharmaceutical research endeavors, a growing need for consistent and repeatable cell culture methodologies, the acceleration of drug discovery initiatives, the accessibility of adaptable automation systems, and the flourishing of life science investigations within academic institutions.

The automated cell cultures sector is poised for significant expansion in the coming years, projected to reach a market valuation of $11.58 billion by the year 2030, driven by a compound annual growth rate of 10.5%. This anticipated growth during the forecast period is underpinned by several key factors, including escalating investments in the production of cell and gene therapies, a heightened demand for efficient high-throughput screening processes, the burgeoning field of personalized medicine research, the increasing integration of automation within laboratory environments, and an intensified emphasis on enabling the scalable manufacturing of biologics. Furthermore, prominent trends anticipated to shape this market include the greater implementation of completely automated cell culture platforms, the wider adoption of robotic systems for liquid handling, the expanding utilization of scalable automation solutions for cell culture, the advancement of closed-system cell processing techniques, and a strengthened focus on ensuring reproducibility and maintaining stringent sterility controls.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20499&type=smp

Automated Cell Cultures Market Industry Drivers: What Is Driving Revenue Growth?

The expansion of biopharmaceutical manufacturing is anticipated to fuel the advancement of the automated cell culture sector moving ahead. Biopharmaceuticals, which are medications developed through biotechnological means such as recombinant DNA technology and cell cultivation, are seeing elevated demand due to their capacity for precise, potent therapies with minimized adverse effects compared to conventional treatments. Automated cell culture systems contribute to improved efficiency and uniformity in biopharmaceutical output by optimizing the stages of cell proliferation, surveillance, and collection. Substantiating this trend, Sartorius, a German entity specializing in life science technologies, reported in July 2025 that worldwide revenues from biopharmaceutical medications ascended by approximately 9% to USD 458 billion in 2024, a rise from the prior year, representing 41% of the overall pharmaceutical market share, up from 40% in 2023. Consequently, the escalating output of biopharmaceuticals is acting as a catalyst for the growth observed in the automated cell culture market.

#Automated Cell Cultures Market Segment Landscape And Growth Potential

The automated cell cultures market covered in this report is segmented –

1) By Type: Modular Automation, Whole Label Automation

2) By Equipment Type: Automated Liquid Handling Systems, Microplate Readers, Robotic Systems, Automated Storage And Retrieval Systems, Other Equipment Types

3) By Application: Biopharmaceuticals Production, Diagnostics, Gene Therapy, Drug Screening And Development, Toxicity Testing, Stem Cell Research, Tissue Engineering And Regenerative Medicine, Personalized Medicine, Other Applications

4) By End User: Pharmaceuticals And Biotechnology Companies, Hospital And Diagnostic Laboratories, Research Institutes, Cell Banks

Subsegments:

1) By Modular Automation: Automated Cell Culture Systems, Robotic Workstations, Modular Bioreactors

2) By Whole Label Automation: Fully Automated Cell Culture Systems, Integrated Cell Culture Platforms, Automated Cell Handling Solutions

#Automated Cell Cultures Market Growth Trends: What Is Influencing The Future Outlook?

The leading entities within the automated cell cultures sector are prioritizing innovation through sophisticated technologies, including artificial intelligence (AI) driven software, as a strategic means to secure market prominence. This integration of AI software in automated cell culture systems serves to refine experimental parameters and boost operational effectiveness by processing live data, thereby promoting superior cell proliferation and output. A notable development occurred in October 2023 when Molecular Devices LLC, a prominent biotechnology firm headquartered in the United States, introduced its CellXpress.ai Automated Cell Culture System, a pioneering solution engineered to accelerate drug discovery initiatives via cutting-edge automation and AI capabilities. This platform is specifically developed to simplify intricate cell culture procedures, liberating scientists to concentrate on more vital aspects of their research while simultaneously elevating both efficiency and dependability.

Automated Cell Cultures Market Competitive Landscape: Who Are The Leading Companies?

Major companies operating in the automated cell cultures market are Hitachi Ltd., Panasonic Holdings Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Corning Incorporated, Lonza Group AG, Nikon healthcare, Sartorius AG, Beckman Coulter Inc., Celltrio Inc., Eppendorf AG, Tecan Trading AG, Shibuya Corp, Hamilton Company, Molecular Devices LLC, FORMULATRIX, Highres Biosolutions, Biotron Healthcare, Agilent Technologies, Miltenyi Biotec

Access The Complete Automated Cell Cultures Market Report:

https://www.thebusinessresearchcompany.com/report/automated-cell-cultures-global-market-report

#Automated Cell Cultures Market Largest Region: Which Geography Holds The Highest Market Share?

North Americawas the largest region in the automated cell cultures market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the automated cell cultures market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Automated Cell Cultures Market’s Market Value Anticipated To Evolve From 2026 To 2030?

The automated cell cultures market size has shown significant development recently. It is forecast to rise from $7.02 billion in 2025 to $7.78 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.8%. The increase observed in previous periods can be linked to intensified biopharmaceutical research, a growing requirement for consistent cell culture methods, the expansion of initiatives for discovering new drugs, the introduction of adaptable automation solutions, and an uplift in academic life science studies.

The automated cell cultures market is projected to experience substantial expansion over the coming years. This market is forecast to reach $11.58 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.5%. This anticipated growth during the forecast period is driven by factors such as increased investments in cell and gene therapy manufacturing, an escalating demand for high-throughput screening, the broadening scope of personalized medicine research, the increasing integration of automation within laboratories, and a heightened emphasis on scalable biologics production. Key trends shaping the market during this period involve the increasing implementation of fully automated cell culture platforms, a rise in the adoption of robotic liquid handling systems, expanding applications of scalable cell culture automation, the widening use of closed-system cell processing, and an intensified focus on ensuring reproducibility and stringent sterility control.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20499&type=smp

What Market Drivers Are Helping Shape The Automated Cell Cultures Market Expansion?

Increased biopharmaceutical production is anticipated to drive the expansion of the automated cell cultures market in the future. Biopharmaceuticals are defined as medical drugs manufactured through biotechnology, encompassing methods such as recombinant DNA technology and cell culture techniques. The rising demand for biopharmaceuticals stems from their capacity to provide targeted and effective treatments with reduced side effects when contrasted with conventional therapies. Automated cell culture improves efficiency and consistency in biopharmaceutical manufacturing by optimizing cell growth, monitoring, and harvesting procedures. As an illustration, Sartorius, an international life science technology firm based in Germany, reported that global sales of biopharmaceutical drugs climbed by approximately 9% to attain USD 458 billion in 2024 by July 2025, marking an increase from the prior year and representing 41% of the total pharmaceutical market, a rise from 40% in 2023. Consequently, the expanding production of biopharmaceuticals is fueling the growth of the automated cell cultures market.

Which Segment Divisions Form The Structure Of The Automated Cell Cultures Market?

The automated cell cultures market covered in this report is segmented –

1) By Type: Modular Automation, Whole Label Automation

2) By Equipment Type: Automated Liquid Handling Systems, Microplate Readers, Robotic Systems, Automated Storage And Retrieval Systems, Other Equipment Types

3) By Application: Biopharmaceuticals Production, Diagnostics, Gene Therapy, Drug Screening And Development, Toxicity Testing, Stem Cell Research, Tissue Engineering And Regenerative Medicine, Personalized Medicine, Other Applications

4) By End User: Pharmaceuticals And Biotechnology Companies, Hospital And Diagnostic Laboratories, Research Institutes, Cell Banks

Subsegments:

1) By Modular Automation: Automated Cell Culture Systems, Robotic Workstations, Modular Bioreactors

2) By Whole Label Automation: Fully Automated Cell Culture Systems, Integrated Cell Culture Platforms, Automated Cell Handling Solutions

What Trends Are Influencing The Automated Cell Cultures Market Outlook?

Companies prominent in the automated cell cultures market are strategically investing in technological advancements, such as integrated artificial intelligence (AI)-powered software, to gain a competitive edge. This integrated AI-powered software in automated cell culture optimizes experimental conditions and enhances operational efficiency by analyzing real-time data to foster better cell growth and productivity. For example, in October 2023, Molecular Devices LLC, a US-based biotechnology company, unveiled the CellXpress.ai Automated Cell Culture System, a significant innovation aimed at streamlining drug discovery processes through advanced automation and artificial intelligence. This system is engineered to simplify complex cell culture workflows, allowing researchers to allocate their attention to more critical tasks while simultaneously boosting efficiency and reliability.

Which Companies Form The Competitive Landscape Of The Automated Cell Cultures Market?

Major companies operating in the automated cell cultures market are Hitachi Ltd., Panasonic Holdings Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Corning Incorporated, Lonza Group AG, Nikon healthcare, Sartorius AG, Beckman Coulter Inc., Celltrio Inc., Eppendorf AG, Tecan Trading AG, Shibuya Corp, Hamilton Company, Molecular Devices LLC, FORMULATRIX, Highres Biosolutions, Biotron Healthcare, Agilent Technologies, Miltenyi Biotec

Access The Complete Automated Cell Cultures Market Report:

https://www.thebusinessresearchcompany.com/report/automated-cell-cultures-global-market-report

Which Region Is The Primary Market For The Automated Cell Cultures Market?

North America was the largest region in the automated cell cultures market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated cell cultures market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Automated Cell Cultures Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=20499&type=smp

Browse Through More Reports Similar to the Global Automated Cell Cultures Market 2026, By The Business Research Company

Cellular Telephone Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cellular-telephone-global-market-report

Cell Cultures Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

Cells Therapy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Automated Cell Cultures Market’s Market Value Anticipated To Evolve From 2026 To 2030?

The automated cell cultures market size has shown significant development recently. It is forecast to rise from $7.02 billion in 2025 to $7.78 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.8%. The increase observed in previous periods can be linked to intensified biopharmaceutical research, a growing requirement for consistent cell culture methods, the expansion of initiatives for discovering new drugs, the introduction of adaptable automation solutions, and an uplift in academic life science studies.

The automated cell cultures market is projected to experience substantial expansion over the coming years. This market is forecast to reach $11.58 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.5%. This anticipated growth during the forecast period is driven by factors such as increased investments in cell and gene therapy manufacturing, an escalating demand for high-throughput screening, the broadening scope of personalized medicine research, the increasing integration of automation within laboratories, and a heightened emphasis on scalable biologics production. Key trends shaping the market during this period involve the increasing implementation of fully automated cell culture platforms, a rise in the adoption of robotic liquid handling systems, expanding applications of scalable cell culture automation, the widening use of closed-system cell processing, and an intensified focus on ensuring reproducibility and stringent sterility control.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20499&type=smp

What Market Drivers Are Helping Shape The Automated Cell Cultures Market Expansion?

Increased biopharmaceutical production is anticipated to drive the expansion of the automated cell cultures market in the future. Biopharmaceuticals are defined as medical drugs manufactured through biotechnology, encompassing methods such as recombinant DNA technology and cell culture techniques. The rising demand for biopharmaceuticals stems from their capacity to provide targeted and effective treatments with reduced side effects when contrasted with conventional therapies. Automated cell culture improves efficiency and consistency in biopharmaceutical manufacturing by optimizing cell growth, monitoring, and harvesting procedures. As an illustration, Sartorius, an international life science technology firm based in Germany, reported that global sales of biopharmaceutical drugs climbed by approximately 9% to attain USD 458 billion in 2024 by July 2025, marking an increase from the prior year and representing 41% of the total pharmaceutical market, a rise from 40% in 2023. Consequently, the expanding production of biopharmaceuticals is fueling the growth of the automated cell cultures market.

Which Segment Divisions Form The Structure Of The Automated Cell Cultures Market?

The automated cell cultures market covered in this report is segmented –

1) By Type: Modular Automation, Whole Label Automation

2) By Equipment Type: Automated Liquid Handling Systems, Microplate Readers, Robotic Systems, Automated Storage And Retrieval Systems, Other Equipment Types

3) By Application: Biopharmaceuticals Production, Diagnostics, Gene Therapy, Drug Screening And Development, Toxicity Testing, Stem Cell Research, Tissue Engineering And Regenerative Medicine, Personalized Medicine, Other Applications

4) By End User: Pharmaceuticals And Biotechnology Companies, Hospital And Diagnostic Laboratories, Research Institutes, Cell Banks

Subsegments:

1) By Modular Automation: Automated Cell Culture Systems, Robotic Workstations, Modular Bioreactors

2) By Whole Label Automation: Fully Automated Cell Culture Systems, Integrated Cell Culture Platforms, Automated Cell Handling Solutions

What Trends Are Influencing The Automated Cell Cultures Market Outlook?

Companies prominent in the automated cell cultures market are strategically investing in technological advancements, such as integrated artificial intelligence (AI)-powered software, to gain a competitive edge. This integrated AI-powered software in automated cell culture optimizes experimental conditions and enhances operational efficiency by analyzing real-time data to foster better cell growth and productivity. For example, in October 2023, Molecular Devices LLC, a US-based biotechnology company, unveiled the CellXpress.ai Automated Cell Culture System, a significant innovation aimed at streamlining drug discovery processes through advanced automation and artificial intelligence. This system is engineered to simplify complex cell culture workflows, allowing researchers to allocate their attention to more critical tasks while simultaneously boosting efficiency and reliability.

Which Companies Form The Competitive Landscape Of The Automated Cell Cultures Market?

Major companies operating in the automated cell cultures market are Hitachi Ltd., Panasonic Holdings Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Corning Incorporated, Lonza Group AG, Nikon healthcare, Sartorius AG, Beckman Coulter Inc., Celltrio Inc., Eppendorf AG, Tecan Trading AG, Shibuya Corp, Hamilton Company, Molecular Devices LLC, FORMULATRIX, Highres Biosolutions, Biotron Healthcare, Agilent Technologies, Miltenyi Biotec

Access The Complete Automated Cell Cultures Market Report:

https://www.thebusinessresearchcompany.com/report/automated-cell-cultures-global-market-report

Which Region Is The Primary Market For The Automated Cell Cultures Market?

North America was the largest region in the automated cell cultures market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated cell cultures market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Automated Cell Cultures Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=20499&type=smp

Browse Through More Reports Similar to the Global Automated Cell Cultures Market 2026, By The Business Research Company

Cellular Telephone Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cellular-telephone-global-market-report

Cell Cultures Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

Cells Therapy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Market Size Of The Cluster Of Differentiation (CD) 79a Antibody Market Compare Between 2026 And 2030?

The market size for the cluster of differentiation (cd) 79a antibody has experienced significant expansion over recent years. Projections indicate a rise from $1.22 billion in 2025 to $1.35 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.5%. Historically, this expansion has been driven by several factors, including the increased application of immunohistochemistry in pathology, the growing incidence of b-cell malignancies, advancements in academic immunology research, the broader accessibility of monoclonal antibody production platforms, and the increasing embrace of flow cytometry techniques.

The cluster of differentiation (cd) 79a antibody market size is projected to experience substantial growth in the coming years. It is anticipated to expand to $2 billion by 2030, achieving a compound annual growth rate (CAGR) of 10.2%. This growth during the forecast period can be attributed to factors such as an increasing demand for precision diagnostics, the expansion of personalized medicine research, rising investments in antibody engineering, the growing adoption of multiplex diagnostic assays, and the development of translational research initiatives. Significant trends expected in the forecast period involve the increasing uptake of recombinant antibody formats, the growing application of cd79a in hematologic cancer diagnostics, a heightened demand for high-specificity B-cell markers, the expansion of automated immunoassay platforms, and an intensified focus on antibody validation standards.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/global-cluster-of-differentiation-cd-79a-antibody-market-report

Which Drivers Are Supporting The Cluster Of Differentiation (CD) 79a Antibody Market Growth?

The increasing need for targeted therapeutics is anticipated to drive the expansion of the cluster of differentiation (CD) 79a antibody market moving ahead. Targeted therapies are medical interventions that specifically identify and block molecular irregularities in conditions like cancer or other diseases, with the goal of improving treatment precision and reducing harm to healthy cells. The rising focus on targeted therapies is primarily fueled by breakthroughs in precision medicine, which allows for personalized, more effective treatments based on individual genetic profiles. CD79a antibodies play a crucial role in targeted therapies by specifically attaching to B-cell markers, making them well-suited for precise treatment of hematologic malignancies. They boost therapeutic efficacy by enabling the selective targeting of cancerous B cells, which leads to better patient outcomes and fewer off-target effects. For instance, in December 2024, according to the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, the Food and Drug Administration (FDA) approved 6 gene therapy products in 2023, up from 5 approvals in 2022. Consequently, the growing demand for targeted therapeutics is propelling the growth of the cluster of differentiation (CD) 79a antibody market.

How Is The Cluster Of Differentiation (CD) 79a Antibody Market Organized By Segment Classification?

The cluster of differentiation (cd) 79a antibody market covered in this report is segmented –

1) By Product Type: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies

2) By Technology: Western Blotting, Immunohistochemistry, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA)

3) By Distribution Channel: Direct Sales, Distributors, Online Sales

4) By End Use: Biotechnology Companies, Pharmaceutical Companies, Academic And Research Institutes, Diagnostic Laboratories

Subsegments:

1) By Monoclonal Antibodies: Mouse Derived Antibodies, Rabbit Derived Antibodies, Human Derived Antibodies, Chimeric Antibodies, Humanized Antibodies

2) By Polyclonal Antibodies: Goat Derived Antibodies, Rabbit Derived Antibodies, Sheep Derived Antibodies, Donkey Derived Antibodies, Horse Derived Antibodies

3) By Recombinant Antibodies: Single Chain Variable Fragment Antibodies, Fragment Antigen Binding Antibodies, Bispecific Antibodies, Nanobodies, Engineered Full Length Antibodies

Which Trends Are Expected To Impact The Cluster Of Differentiation (CD) 79a Antibody Market?

Major companies in the cluster of differentiation (CD) 79a antibody market are concentrating on creating sophisticated solutions, such as adaptable multiplex immunohistochemistry (IHC) assays, to speed up research, boost data quality, and simplify complex manual workflows. Adaptable multiplex IHC involves advanced laboratory methods that allow for the simultaneous identification of numerous biomarkers on a single tissue sample, maintaining spatial context. For instance, in September 2023, Cell Signaling Technology (CST), a US-based biotechnology firm, introduced the SignalStar Multiplex IHC platform. This spatial biology offering is an adaptable, antibody-centric platform facilitating highly multiplexed experiments with up to 8-plex amplification within just two days. It features integrated panel design assistance and optimized protocols, enabling straightforward biomarker detection and data generation without extensive fine-tuning. This innovation enhances diagnostic precision, throughput, and spatial resolution in tissue-based analysis, marking a notable progression in the CD79a antibody field.

Who Are The Industry Participants Involved In The Cluster Of Differentiation (CD) 79a Antibody Market?

Major companies operating in the cluster of differentiation (cd) 79a antibody market are Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Miltenyi Biotec B.V. & Co. KG, GenScript Biotech Corporation, Cell Signaling Technology Inc., Sino Biological Inc., Proteintech Group Inc., Santa Cruz Biotechnology Inc., OriGene Technologies Inc., GeneTex Inc., Abnova Corporation, RayBiotech Life Inc., Wuhan Fine Biotech Co. Ltd. (commonly known as FineTest), Aviva Systems Biology Corporation, EXBIO Praha a.s., NSJ Bioreagents Inc., Boster Biological Technology Co. Ltd., Bioss Antibodies Inc.

Get The Full Cluster Of Differentiation (CD) 79a Antibody Market Report:

https://www.thebusinessresearchcompany.com/report/global-cluster-of-differentiation-cd-79a-antibody-market-report

Which Region Represents The Largest Share Of The Cluster Of Differentiation (CD) 79a Antibody Market?

North America was the largest region in the cluster of differentiation (CD) 79a antibody market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cluster of differentiation (cd) 79a antibody market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cluster Of Differentiation (CD) 79a Antibody Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/global-cluster-of-differentiation-cd-79a-antibody-market-report

Browse Through More Reports Similar to the Global Cluster Of Differentiation (CD) 79a Antibody Market 2026, By The Business Research Company

Monoclonal Antibodies Market Report 2026

https://www.thebusinessresearchcompany.com/report/monoclonal-antibodies-global-market-report

Polyclonal Antibodies Market Report 2026

https://www.thebusinessresearchcompany.com/report/polyclonal-antibodies-global-market-report

Research Antibodie And Reagent Market Report 2026

https://www.thebusinessresearchcompany.com/report/research-antibodie-and-reagent-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Automated Cell Cultures Market Be By 2030 Compared To Its 2026 Market Size?

The market size for automated cell cultures has experienced significant growth recently. This market is projected to expand from $7.02 billion in 2025 to $7.78 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.8%. Historically, this expansion has been driven by factors such as increased biopharmaceutical research activity, a growing need for standardized cell culture processes, the broadening of drug discovery programs, the availability of modular automation solutions, and the expansion of academic life science research.

The market for automated cell cultures is projected to experience swift expansion in the coming years, anticipated to reach a valuation of $11.58 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.5%. This growth during the forecast period is primarily driven by increasing investments in cell and gene therapy manufacturing, a rising demand for high-throughput screening, the expansion of personalized medicine research, growing adoption of automation in laboratories, and an increasing focus on scalable biologics production. Furthermore, major trends in the forecast period include the increasing deployment of fully automated cell culture platforms, rising adoption of robotic liquid handling systems, the growing use of scalable cell culture automation, expansion of closed-system cell processing, and an enhanced focus on reproducibility and sterility control.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/automated-cell-cultures-global-market-report

Which Key Factors Are Driving The Automated Cell Cultures Market Growth?

The rising output of biopharmaceuticals is projected to drive the expansion of the automated cell cultures market in the coming years. Biopharmaceuticals are medicinal substances created using biotechnological approaches, including recombinant DNA technology and cell culture methods. The increasing need for biopharmaceuticals is fueled by their capacity to deliver targeted, potent treatments with fewer adverse reactions when contrasted with conventional therapies. Automated cell culture improves both the efficiency and consistency of biopharmaceutical manufacturing by optimizing procedures for cell proliferation, monitoring, and harvesting. For example, in July 2025, according to Sartorius, an international life science technology company based in Germany, worldwide sales of biopharmaceutical medications grew by approximately 9% to reach USD 458 billion in 2024, an increase from the preceding year. This accounted for 41% of the total pharmaceutical market, up from 40% in 2023. Hence, the escalating production of biopharmaceuticals is propelling the growth of the automated cell cultures market.

How Is The Automated Cell Cultures Market Organized By Segment Classification?

The automated cell cultures market covered in this report is segmented –

1) By Type: Modular Automation, Whole Label Automation

2) By Equipment Type: Automated Liquid Handling Systems, Microplate Readers, Robotic Systems, Automated Storage And Retrieval Systems, Other Equipment Types

3) By Application: Biopharmaceuticals Production, Diagnostics, Gene Therapy, Drug Screening And Development, Toxicity Testing, Stem Cell Research, Tissue Engineering And Regenerative Medicine, Personalized Medicine, Other Applications

4) By End User: Pharmaceuticals And Biotechnology Companies, Hospital And Diagnostic Laboratories, Research Institutes, Cell Banks

Subsegments:

1) By Modular Automation: Automated Cell Culture Systems, Robotic Workstations, Modular Bioreactors

2) By Whole Label Automation: Fully Automated Cell Culture Systems, Integrated Cell Culture Platforms, Automated Cell Handling Solutions

Which Trends Are Guiding The Direction Of The Automated Cell Cultures Market?

Major companies operating in the automated cell cultures market are increasingly focusing on technological advancements, such as the integration of artificial intelligence (AI)-powered software, to gain a competitive edge. This integrated AI-powered software optimizes experimental conditions and enhances operational efficiency by thoroughly analyzing real-time data, consequently improving cell growth and overall productivity. For instance, in October 2023, Molecular Devices LLC, a US-based biotechnology company, launched the CellXpress.ai Automated Cell Culture System, a pioneering innovation aimed at refining drug discovery processes through advanced automation and artificial intelligence. This system is engineered to simplify complex cell culture workflows, thereby enabling researchers to concentrate on more crucial assignments while concurrently boosting efficiency and reliability.

Who Are The Industry Participants Involved In The Automated Cell Cultures Market?

Major companies operating in the automated cell cultures market are Hitachi Ltd., Panasonic Holdings Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Corning Incorporated, Lonza Group AG, Nikon healthcare, Sartorius AG, Beckman Coulter Inc., Celltrio Inc., Eppendorf AG, Tecan Trading AG, Shibuya Corp, Hamilton Company, Molecular Devices LLC, FORMULATRIX, Highres Biosolutions, Biotron Healthcare, Agilent Technologies, Miltenyi Biotec

Get The Full Automated Cell Cultures Market Report:

https://www.thebusinessresearchcompany.com/report/automated-cell-cultures-global-market-report

Which Geographic Region Dominates The Automated Cell Cultures Market?

North America was the largest region in the automated cell cultures market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated cell cultures market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Automated Cell Cultures Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/automated-cell-cultures-global-market-report

Browse Through More Reports Similar to the Global Automated Cell Cultures Market 2026, By The Business Research Company

Cells Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Cellular Telephone Market Report 2026

https://www.thebusinessresearchcompany.com/report/cellular-telephone-global-market-report

Cell Cultures Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Automated Cell Cultures Market Be By 2030 Compared To Its 2026 Market Size?

The market size for automated cell cultures has experienced significant growth recently. This market is projected to expand from $7.02 billion in 2025 to $7.78 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.8%. Historically, this expansion has been driven by factors such as increased biopharmaceutical research activity, a growing need for standardized cell culture processes, the broadening of drug discovery programs, the availability of modular automation solutions, and the expansion of academic life science research.

The market for automated cell cultures is projected to experience swift expansion in the coming years, anticipated to reach a valuation of $11.58 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.5%. This growth during the forecast period is primarily driven by increasing investments in cell and gene therapy manufacturing, a rising demand for high-throughput screening, the expansion of personalized medicine research, growing adoption of automation in laboratories, and an increasing focus on scalable biologics production. Furthermore, major trends in the forecast period include the increasing deployment of fully automated cell culture platforms, rising adoption of robotic liquid handling systems, the growing use of scalable cell culture automation, expansion of closed-system cell processing, and an enhanced focus on reproducibility and sterility control.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/automated-cell-cultures-global-market-report

Which Key Factors Are Driving The Automated Cell Cultures Market Growth?

The rising output of biopharmaceuticals is projected to drive the expansion of the automated cell cultures market in the coming years. Biopharmaceuticals are medicinal substances created using biotechnological approaches, including recombinant DNA technology and cell culture methods. The increasing need for biopharmaceuticals is fueled by their capacity to deliver targeted, potent treatments with fewer adverse reactions when contrasted with conventional therapies. Automated cell culture improves both the efficiency and consistency of biopharmaceutical manufacturing by optimizing procedures for cell proliferation, monitoring, and harvesting. For example, in July 2025, according to Sartorius, an international life science technology company based in Germany, worldwide sales of biopharmaceutical medications grew by approximately 9% to reach USD 458 billion in 2024, an increase from the preceding year. This accounted for 41% of the total pharmaceutical market, up from 40% in 2023. Hence, the escalating production of biopharmaceuticals is propelling the growth of the automated cell cultures market.

How Is The Automated Cell Cultures Market Organized By Segment Classification?

The automated cell cultures market covered in this report is segmented –

1) By Type: Modular Automation, Whole Label Automation

2) By Equipment Type: Automated Liquid Handling Systems, Microplate Readers, Robotic Systems, Automated Storage And Retrieval Systems, Other Equipment Types

3) By Application: Biopharmaceuticals Production, Diagnostics, Gene Therapy, Drug Screening And Development, Toxicity Testing, Stem Cell Research, Tissue Engineering And Regenerative Medicine, Personalized Medicine, Other Applications

4) By End User: Pharmaceuticals And Biotechnology Companies, Hospital And Diagnostic Laboratories, Research Institutes, Cell Banks

Subsegments:

1) By Modular Automation: Automated Cell Culture Systems, Robotic Workstations, Modular Bioreactors

2) By Whole Label Automation: Fully Automated Cell Culture Systems, Integrated Cell Culture Platforms, Automated Cell Handling Solutions

Which Trends Are Guiding The Direction Of The Automated Cell Cultures Market?

Major companies operating in the automated cell cultures market are increasingly focusing on technological advancements, such as the integration of artificial intelligence (AI)-powered software, to gain a competitive edge. This integrated AI-powered software optimizes experimental conditions and enhances operational efficiency by thoroughly analyzing real-time data, consequently improving cell growth and overall productivity. For instance, in October 2023, Molecular Devices LLC, a US-based biotechnology company, launched the CellXpress.ai Automated Cell Culture System, a pioneering innovation aimed at refining drug discovery processes through advanced automation and artificial intelligence. This system is engineered to simplify complex cell culture workflows, thereby enabling researchers to concentrate on more crucial assignments while concurrently boosting efficiency and reliability.

Who Are The Industry Participants Involved In The Automated Cell Cultures Market?

Major companies operating in the automated cell cultures market are Hitachi Ltd., Panasonic Holdings Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Corning Incorporated, Lonza Group AG, Nikon healthcare, Sartorius AG, Beckman Coulter Inc., Celltrio Inc., Eppendorf AG, Tecan Trading AG, Shibuya Corp, Hamilton Company, Molecular Devices LLC, FORMULATRIX, Highres Biosolutions, Biotron Healthcare, Agilent Technologies, Miltenyi Biotec

Get The Full Automated Cell Cultures Market Report:

https://www.thebusinessresearchcompany.com/report/automated-cell-cultures-global-market-report

Which Geographic Region Dominates The Automated Cell Cultures Market?

North America was the largest region in the automated cell cultures market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated cell cultures market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Automated Cell Cultures Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/automated-cell-cultures-global-market-report

Browse Through More Reports Similar to the Global Automated Cell Cultures Market 2026, By The Business Research Company

Cells Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Cellular Telephone Market Report 2026

https://www.thebusinessresearchcompany.com/report/cellular-telephone-global-market-report

Cell Cultures Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Automated Cell Cultures Market From 2026 To 2030?

The automated cell cultures market has expanded significantly in recent years. It is projected to increase from $7.02 billion in 2025 to $7.78 billion in 2026, advancing at a compound annual growth rate (CAGR) of 10.8%. This historical growth can be linked to increasing biopharmaceutical research activity, a rising demand for standardized cell culture processes, the expansion of drug discovery programs, the availability of modular automation solutions, and the growth in academic life science research.

The automated cell cultures market size is projected to experience substantial expansion over the coming years, reaching a valuation of $11.58 billion by 2030, with a compound annual growth rate (CAGR) of 10.5%. This anticipated growth is driven by several factors, including heightened investments in cell and gene therapy manufacturing, an escalating demand for high-throughput screening methods, the broadening scope of personalized medicine research, the increasing integration of automation in laboratory settings, and a reinforced emphasis on scalable biologics production. Key trends anticipated during this period encompass the wider deployment of fully automated cell culture platforms, an uptick in the adoption of robotic liquid handling systems, the expanding utilization of scalable cell culture automation, the proliferation of closed-system cell processing techniques, and a sharpened focus on ensuring reproducibility and sterility control.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20499&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Automated Cell Cultures Market?

The projected increase in the manufacturing of biopharmaceuticals is expected to drive the expansion of the automated cell cultures market going forward. Biopharmaceuticals are medicinal products created using biotechnology methods, including recombinant DNA technology and cell culture techniques. The rising consumer demand for biopharmaceuticals is attributed to their capability to provide targeted, effective treatments with fewer adverse effects compared to traditional medical approaches. Automated cell culture boosts efficiency and consistency in biopharmaceutical production by optimizing the procedures for cell growth, monitoring, and harvesting. For instance, in July 2025, according to Sartorius, a Germany-based international life science technology company, global sales of biopharmaceutical drugs rose by about 9% to reach USD 458 billion in 2024, up from the previous year, accounting for 41% of the total pharmaceutical market compared with 40% in 2023. Thus, the escalating production of biopharmaceuticals is propelling the growth of the automated cell cultures market.

Which Segments Are Included In The Analysis Of The Automated Cell Cultures Market?

The automated cell cultures market covered in this report is segmented –

1) By Type: Modular Automation, Whole Label Automation

2) By Equipment Type: Automated Liquid Handling Systems, Microplate Readers, Robotic Systems, Automated Storage And Retrieval Systems, Other Equipment Types

3) By Application: Biopharmaceuticals Production, Diagnostics, Gene Therapy, Drug Screening And Development, Toxicity Testing, Stem Cell Research, Tissue Engineering And Regenerative Medicine, Personalized Medicine, Other Applications

4) By End User: Pharmaceuticals And Biotechnology Companies, Hospital And Diagnostic Laboratories, Research Institutes, Cell Banks

Subsegments:

1) By Modular Automation: Automated Cell Culture Systems, Robotic Workstations, Modular Bioreactors

2) By Whole Label Automation: Fully Automated Cell Culture Systems, Integrated Cell Culture Platforms, Automated Cell Handling Solutions

What Trends Are Projected To Affect The Automated Cell Cultures Market?

Key companies operating in the automated cell cultures market are increasingly focusing on technological advancements, such as integrated artificial intelligence (AI)-powered software, to gain a competitive advantage. This integrated AI-powered software within automated cell culture systems optimizes experimental conditions and enhances efficiency by meticulously analyzing real-time data, leading to improved cell growth and productivity. For example, in October 2023, Molecular Devices LLC, a US-based biotechnology company, unveiled the CellXpress.ai Automated Cell Culture System, a significant innovation aimed at improving drug discovery processes through advanced automation and artificial intelligence. This particular system is engineered to streamline complex cell culture workflows, thereby enabling researchers to concentrate on more critical tasks while simultaneously enhancing overall efficiency and reliability.

Which Key Industry Participants Are Active In The Automated Cell Cultures Market?

Major companies operating in the automated cell cultures market are Hitachi Ltd., Panasonic Holdings Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Corning Incorporated, Lonza Group AG, Nikon healthcare, Sartorius AG, Beckman Coulter Inc., Celltrio Inc., Eppendorf AG, Tecan Trading AG, Shibuya Corp, Hamilton Company, Molecular Devices LLC, FORMULATRIX, Highres Biosolutions, Biotron Healthcare, Agilent Technologies, Miltenyi Biotec

Read the full automated cell cultures market report here:

https://www.thebusinessresearchcompany.com/report/automated-cell-cultures-global-market-report

What Are The Leading Geographic Regions In The Automated Cell Cultures Market?

North America was the largest region in the automated cell cultures market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated cell cultures market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Automated Cell Cultures Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20499&type=smp

Browse Through More Reports Similar to the Global Automated Cell Cultures Market 2026, By The Business Research Company

Cellular Telephone Global Market Report

https://www.thebusinessresearchcompany.com/report/cellular-telephone-global-market-report

Cell Cultures Global Market Report

https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

Cells Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model